Búsqueda | Portal de Búsqueda de la BVS España

1.

Recombinant von Willebrand factor prophylaxis in patients with severe von Willebrand disease: phase 3 study results.

Leebeek, Frank W G; Peyvandi, Flora; Escobar, Miguel; Tiede, Andreas; Castaman, Giancarlo; Wang, Michael; Wynn, Tung; Baptista, Jovanna; Wang, Yi; Zhang, Jingmei; Mellgård, Björn; Özen, Gülden.

Blood; 140(2): 89-98, 2022 07 14.

Artículo en Inglés | MEDLINE | ID: mdl-35439298

2.

Acquired bleeding disorders.

Tiede, Andreas; Susen, Sophie; Lisman, Ton.

Haemophilia; 30 Suppl 3: 29-38, 2024 Apr.

Artículo en Africano | MEDLINE | ID: mdl-38562115

3.

Correction: Pathological mechanism and antisense oligonucleotide-mediated rescue of a non-coding variant suppressing factor 9 RNA biogenesis leading to hemophilia B.

Krooss, Simon; Werwitzke, Sonja; Kopp, Johannes; Rovai, Alice; Varnholt, Dirk; Wachs, Amelie S; Goyenvalle, Aurelie; Aartsma-Rus, Annemieke; Ott, Michael; Tiede, Andreas; Langemeier, Jörg; Bohne, Jens.

PLoS Genet; 17(1): e1009345, 2021 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-33507897

4.

Management of Cerebral Venous Thrombosis Due to Adenoviral COVID-19 Vaccination.

Scutelnic, Adrian; Krzywicka, Katarzyna; Mbroh, Joshua; van de Munckhof, Anita; van Kammen, Mayte Sánchez; de Sousa, Diana Aguiar; Lindgren, Erik; Jood, Katarina; Günther, Albrecht; Hiltunen, Sini; Putaala, Jukka; Tiede, Andreas; Maier, Frank; Kern, Rolf; Bartsch, Thorsten; Althaus, Katharina; Ciccone, Alfonso; Wiedmann, Markus; Skjelland, Mona; Medina, Antonio; Cuadrado-Godia, Elisa; Cox, Thomas; Aujayeb, Avinash; Raposo, Nicolas; Garambois, Katia; Payen, Jean-Francois; Vuillier, Fabrice; Franchineau, Guillaume; Timsit, Serge; Bougon, David; Dubois, Marie-Cécile; Tawa, Audrey; Tracol, Clement; De Maistre, Emmanuel; Bonneville, Fabrice; Vayne, Caroline; Mengel, Annerose; Michalski, Dominik; Pelz, Johann; Wittstock, Matthias; Bode, Felix; Zimmermann, Julian; Schouten, Judith; Buture, Alina; Murphy, Sean; Palma, Vincenzo; Negro, Alberto; Gutschalk, Alexander; Nagel, Simon; Schoenenberger, Silvia.

Ann Neurol; 92(4): 562-573, 2022 10.

Artículo en Inglés | MEDLINE | ID: mdl-35689346

5.

Recombinant VWF fragments improve bioavailability of subcutaneous factor VIII in hemophilia A mice.

Vollack-Hesse, Nadine; Oleshko, Olga; Werwitzke, Sonja; Solecka-Witulska, Barbara; Kannicht, Christoph; Tiede, Andreas.

Blood; 137(8): 1072-1081, 2021 02 25.

Artículo en Inglés | MEDLINE | ID: mdl-32877516

6.

Prothrombotic immune thrombocytopenia after COVID-19 vaccination.

Tiede, Andreas; Sachs, Ulrich J; Czwalinna, Andreas; Werwitzke, Sonja; Bikker, Rolf; Krauss, Joachim K; Donnerstag, Frank; Weißenborn, Karin; Höglinger, Günter; Maasoumy, Benjamin; Wedemeyer, Heiner; Ganser, Arnold.

Blood; 138(4): 350-353, 2021 07 29.

Artículo en Inglés | MEDLINE | ID: mdl-34323939

7.

Prophylaxis with recombinant von Willebrand factor in patients with type 3 von Willebrand disease: Results of a post hoc analysis from a phase 3 trial.

Leebeek, Frank W G; Peyvandi, Flora; Tiede, Andreas; Castaman, Giancarlo; Escobar, Miguel; Wang, Michael; Zülfikar, Bulent; Susen, Sophie; Miesbach, Wolfgang; Wang, Scarlett; Wang, Yi; Zhang, Jingmei; Özen, Gülden.

Eur J Haematol; 111(1): 29-40, 2023 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-36823994

8.

Microembolic signal monitoring in patients with HeartMate 3 and HeartWare left ventricular assist devices: Association with antithrombotic treatment and cerebrovascular events.

Ravenberg, Kim Kristin; Gabriel, Maria Magdalena; Leotescu, Andrei; Tran, Anh Thu; Grosse, Gerrit Maximilian; Schuppner, Ramona; Ernst, Johanna; Lichtinghagen, Ralf; Tiede, Andreas; Werwitzke, Sonja; Bara, Christoph Leon; Schmitto, Jan Dieter; Weissenborn, Karin; Hanke, Jasmin Sarah; Worthmann, Hans.

Artif Organs; 47(2): 370-379, 2023 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-36114791

9.

Pathological mechanism and antisense oligonucleotide-mediated rescue of a non-coding variant suppressing factor 9 RNA biogenesis leading to hemophilia B.

Krooss, Simon; Werwitzke, Sonja; Kopp, Johannes; Rovai, Alice; Varnholt, Dirk; Wachs, Amelie S; Goyenvalle, Aurelie; Aarstma-Rus, Annemieke; Ott, Michael; Tiede, Andreas; Langemeier, Jörg; Bohne, Jens.

PLoS Genet; 16(4): e1008690, 2020 04.

Artículo en Inglés | MEDLINE | ID: mdl-32267853

10.

[Use of Thrombopoetin-Receptor-Agonists (TPO-RA) in patients with liver cirrhosis before invasive procedures]. / Einsatz von Thrombopoetin-Rezeptor-Agonisten (TPO-RA) vor invasiven Eingriffen bei Patienten mit Leberzirrhose.

Mücke, Marcus M; Bruns, Tony; Canbay, Ali; Matzdorff, Axel; Tacke, Frank; Tiede, Andreas; Trebicka, Jonel; Wedemeyer, Heiner; Zacharowski, Kai; Zeuzem, Stefan; Lange, Christian M.

Z Gastroenterol; 61(9): 1225-1234, 2023 Sep.

Artículo en Alemán | MEDLINE | ID: mdl-36377140

11.

Bleeding and response to hemostatic therapy in acquired hemophilia A: results from the GTH-AH 01/2010 study.

Holstein, Katharina; Liu, Xiaofei; Smith, Andrea; Knöbl, Paul; Klamroth, Robert; Geisen, Ulrich; Eichler, Hermann; Miesbach, Wolfgang; Tiede, Andreas.

Blood; 136(3): 279-287, 2020 07 16.

Artículo en Inglés | MEDLINE | ID: mdl-32268359

12.

Clinical outcomes after joint surgery in patients on turoctocog alfa pegol (N8-GP) prophylaxis: A post hoc analysis.

Hampton, Kingsley; Tiede, Andreas; Shivamurthy, Shwetha; Chowdary, Pratima.

Haemophilia; 28(1): 158-165, 2022 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-34811856

13.

Acquired bleeding disorders.

Tiede, Andreas; Zieger, Barbara; Lisman, Ton.

Haemophilia; 28 Suppl 4: 68-76, 2022 May.

Artículo en Inglés | MEDLINE | ID: mdl-35521729

14.

Post-hoc analysis on the long-term response to fixed-dose prophylaxis with N8-GP in patients with haemophilia A.

Tiede, Andreas; Hampton, Kingsley; Jiménez-Yuste, Victor; Young, Guy; Benchikh El Fegoun, Soraya; Chowdary, Pratima.

Haemophilia; 28(1): 27-35, 2022 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-34562332

15.

Electronic diaries in the management of haemophilia gene therapy: Perspective of an expert group from the German, Austrian and Swiss Society on Thrombosis and Haemostasis (GTH).

Miesbach, Wolfgang; Eichler, Hermann; Holstein, Katharina; Holzhauer, Susanne; Klamroth, Robert; Knöfler, Ralf; Male, Christoph; Olivieri, Martin; Oldenburg, Johannes; Tiede, Andreas.

Haemophilia; 28(2): 264-269, 2022 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-35182445

16.

Safety of intramuscular COVID-19 vaccination in patients with haemophilia.

Tiede, Andreas; Leise, Hendrik; Horneff, Silvia; Oldenburg, Johannes; Halimeh, Susan; Heller, Christine; Königs, Christoph; Holstein, Katharina; Pfrepper, Christian.

Haemophilia; 28(5): 687-693, 2022 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-35561276

17.

Distinct Mechanisms of IgM Antibody-Mediated Acquired von Willebrand Syndrome and Successful Treatment with Recombinant von Willebrand Factor in One Patient.

Höpting, Matthias; Budde, Ulrich; Tiede, Andreas; Grube, Matthias; Hahn, Joachim; Herr, Wolfgang; Heimerl, Susanne; Hart, Christina.

Acta Haematol; 145(4): 454-457, 2022.

Artículo en Inglés | MEDLINE | ID: mdl-35086107

18.

Factor VIII activity and bleeding risk during prophylaxis for severe hemophilia A: a population pharmacokinetic model.

Tiede, Andreas; Abdul Karim, Faraizah; Jiménez-Yuste, Victor; Klamroth, Robert; Lejniece, Sandra; Suzuki, Takashi; Groth, Andreas; Santagostino, Elena.

Haematologica; 106(7): 1902-1909, 2021 07 01.

Artículo en Inglés | MEDLINE | ID: mdl-32327501

19.

Acquired bleeding disorders.

Tiede, Andreas; Zieger, Barbara; Lisman, Ton.

Haemophilia; 27 Suppl 3: 5-13, 2021 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-32476241

20.

Monitoring of different factor VIII replacement products using a factor VIII one-stage clotting assay on cobas t 511/711 analysers.

Ketteler, Carolin; Hoffmann, Ingrid; Davidson, Simon; Tiede, Andreas; Richter, Nina.

Haemophilia; 27(6): e704-e712, 2021 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-34590394

Portal de Búsqueda de la BVS España

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

Recombinant von Willebrand factor prophylaxis in patients with severe von Willebrand disease: phase 3 study results.

Acquired bleeding disorders.

Correction: Pathological mechanism and antisense oligonucleotide-mediated rescue of a non-coding variant suppressing factor 9 RNA biogenesis leading to hemophilia B.

Management of Cerebral Venous Thrombosis Due to Adenoviral COVID-19 Vaccination.

Recombinant VWF fragments improve bioavailability of subcutaneous factor VIII in hemophilia A mice.

Prothrombotic immune thrombocytopenia after COVID-19 vaccination.

Prophylaxis with recombinant von Willebrand factor in patients with type 3 von Willebrand disease: Results of a post hoc analysis from a phase 3 trial.

Microembolic signal monitoring in patients with HeartMate 3 and HeartWare left ventricular assist devices: Association with antithrombotic treatment and cerebrovascular events.

Pathological mechanism and antisense oligonucleotide-mediated rescue of a non-coding variant suppressing factor 9 RNA biogenesis leading to hemophilia B.

[Use of Thrombopoetin-Receptor-Agonists (TPO-RA) in patients with liver cirrhosis before invasive procedures]. / Einsatz von Thrombopoetin-Rezeptor-Agonisten (TPO-RA) vor invasiven Eingriffen bei Patienten mit Leberzirrhose.

Bleeding and response to hemostatic therapy in acquired hemophilia A: results from the GTH-AH 01/2010 study.

Clinical outcomes after joint surgery in patients on turoctocog alfa pegol (N8-GP) prophylaxis: A post hoc analysis.

Acquired bleeding disorders.

Post-hoc analysis on the long-term response to fixed-dose prophylaxis with N8-GP in patients with haemophilia A.

Electronic diaries in the management of haemophilia gene therapy: Perspective of an expert group from the German, Austrian and Swiss Society on Thrombosis and Haemostasis (GTH).

Safety of intramuscular COVID-19 vaccination in patients with haemophilia.

Distinct Mechanisms of IgM Antibody-Mediated Acquired von Willebrand Syndrome and Successful Treatment with Recombinant von Willebrand Factor in One Patient.

Factor VIII activity and bleeding risk during prophylaxis for severe hemophilia A: a population pharmacokinetic model.

Acquired bleeding disorders.

Monitoring of different factor VIII replacement products using a factor VIII one-stage clotting assay on cobas t 511/711 analysers.